Skip to main content
Veterinary Medicines

HuveGuard NB

Authorised
  • Eimeria brunetti, strain Roybru 3+28, Live
  • Eimeria necatrix, strain Mednec 3+8, Live

Product identification

Medicine name:
HuveGuard NB
HuveGuard NB vet suspensio oraalisuspensiota varten kanoille
Active substance:
  • Eimeria brunetti, strain Roybru 3+28, Live
  • Eimeria necatrix, strain Mednec 3+8, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Eimeria brunetti, strain Roybru 3+28, Live
    50.00
    oocyst(s)
    /
    0.03
    millilitre(s)
  • Eimeria necatrix, strain Mednec 3+8, Live
    100.00
    oocyst(s)
    /
    0.03
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 5 vials of 5000 doses (1 dose = 0.025 ml)
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 10 vials of 1000 doses (1 dose = 0.025 ml)
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 1 vial of 5000 doses (1 dose = 0.025 ml)
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 1 vial of 1000 doses (1 dose = 0.025 ml)
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 5 vials of 1000 doses (1 dose = 0.025 ml)
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 10 vials of 5000 doses (1 dose = 0.025 ml)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 33935
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0207/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Malta
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 16/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 16/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."